Top Markets
Coin of the day
Zynerba Pharmaceuticals, Inc. Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc.

ZYNE
Hisse Senetlerindeki Sıralama #26763
Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in... Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in the clinical development phase. Its primary objective is to create and advance medicinal transdermal cannabinoid treatments specifically for uncommon and scarcely encountered neuropsychiatric conditions. A key product in its pipeline is Zygel, a pharmaceutical-grade cannabidiol expertly crafted into a gel with enhanced skin penetration for topical application. Originally established as AllTranz, Inc., the company adopted its current name, Zynerba Pharmaceuticals, Inc., in August 2014. Founded in 2007, Zynerba Pharmaceuticals maintains its headquarters in Devon, Pennsylvania.
Hisse Fiyatı
$1.30
Son senkronizasyon: 2023-10-13
Piyasa Değeri
$38.02M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Zynerba Pharmaceuticals, Inc. (ZYNE)

Kategori

Zynerba Pharmaceuticals, Inc. (ZYNE) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $1.27 - 2023-10-01

Gün sonu en düşük fiyat: $28.18 - 2015-08-01
Zynerba Pharmaceuticals, Inc. için hisse fiyatı geçmişi: 2015 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2023 121.20%
2022 -82.15%
2021 -16.92%
2020 -34.43%
2019 51.25%
2018 -67.91%
2017 -17.16%
2016 20.03%
2015 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$171.67 -
DE
$162.44 24.86%
DE
$38.00 22.72%
JP
$221.55 33.82%
CH
$21.01 11.96%
IN